D Sandford Smith

Affiliations

  • Director at Cytokinetics Inc (CYTK), 2024-01-03
  • Director at Akcea Therapeutics Inc. (AKCA), 2020-10-13
  • Director at Neuralstem Inc. (CUR), 2019-07-03
  • Director at Apricus Biosciences Inc. (APRI), 2018-01-08
  • Director at Novelion Therapeutics Inc. (NVLN), 2017-02-03
  • Director at Aegerion Pharmaceuticals Inc. (AEGR), 2016-12-01
  • Exe Vp,President Int'l Group at Genzyme Corp (GENZ), 2011-04-06
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
APRI $1.59 18,200 $28,998.06 26,500 2014-10-23 Filing
APRI $1.52 8,300 $12,650.86 8,300 2014-10-22 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
CYTK $53.97 11,369 $613,584.93 12,170 2022-09-02 Filing
CYTK $45.79 4,124 $188,837.96 6,765 2021-12-27 Filing
CYTK $45.79 20,000 $915,800.00 6,765 2021-12-27 Filing
CYTK $45.79 4,166 $190,761.14 6,765 2021-12-27 Filing
CYTK $41.21 4,032 $166,140.17 6,765 2021-11-19 Filing